Lonza invests in India

Lonza will invest $150m in a two-stage project in Genome valley, Hyderabad, India. The first phase of the development, which is due to be operational in 2011-2013, is for R&D labs for 100 people, a small-scale multi-purpose manufacturing plant for biopharmaceuticals, and a small-scale bio-therapeutic media manufacturing plant. The second phase of the development, which is due to be operational in 2014-2015 includes expanded media manufacturing capacity for bio-therapeutic media, additional R&D lab capacity for biologics for 200 researchers, and expanded large-scale manufacturing plant for biopharmaceuticals.
Fierce Biotech